שנת פרסום ראשונה: 2000
שנת עדכון: נובמבר 2012
מפרסם: British Society for Haematology
This document updates UK Haemophilia Centre Doctors Organization (UKHCDO) guidelines on the management of factor VIII/IX (FVIII/IX) inhibitors in congenital haemophilia (Hay et al, 2000, 2006). Acquired haemophilia is excluded and will be covered separately. Most data apply to FVIII inhibitors and the recommendations for FIX inhibitors are sometimes extrapolated from this.
British Journal of Haematology, 2013, 160, 153–170 , doi:10.1111/bjh.12091